Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-1851.42%EBITDA Margin
VS
Market
Sector
Industry
History
$ 9.43Close
$ 3.99 - $ 45.62 52-Week Range
Ticker Information
Ticker
ALGSCompany Name
ALIGOS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQALIGOS THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ALGS - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -58.76M | -1851.42% | $ 3.17M |
| 3/31/2025 | $ -68.53M | -2095.75% | $ 3.27M |
| 12/31/2024 | $ -132.66M | -3362.84% | $ 3.94M |
| 9/30/2024 | $ -91.86M | -1531.8% | $ 6M |
| 6/30/2024 | $ -90.79M | -1139.55% | $ 7.97M |
| 3/31/2024 | $ -83.36M | -604.38% | $ 13.79M |
| 12/31/2023 | $ -85.06M | -547.74% | $ 15.53M |
| 9/30/2023 | $ -81.62M | -498.14% | $ 16.39M |
| 6/30/2023 | $ -81.27M | -471.09% | $ 17.25M |
| 3/31/2023 | $ -82.41M | -586.14% | $ 14.06M |
Key Performance Insights, Last 5 Years
- ALIGOS THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
- Over the past 5 years, ALIGOS THERAPEUTICS INC's average EBITDA % has been -1672.71%.
- The median EBITDA % for ALIGOS THERAPEUTICS INC during this period was -1507.27%
- ALIGOS THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at -471.09%.
- The lowest EBITDA % recorded by ALIGOS THERAPEUTICS INC in the same timeframe -4463.63%
ALIGOS THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for ALIGOS THERAPEUTICS INC is calculated as follows: EBITDA [ $ -94.51M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ] ALGS - EBITDA Margin, Last 5 years
-4463.63%
Minimum
Jun 30, 2021
-471.09%
Maximum
Jun 30, 2023
-1672.71%
Average
-1507.27%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |